Staging and reporting of urothelial carcinoma of the urinary bladder.
Significant progress has been made in the standardization of bladder neoplasm classification and reporting. Accurate staging using the American Joint Committee on Cancer/International Union Against Cancer (AJCC/UICC) TNM system is essential for patient management, and has been reinforced by clinical evidence in recent years. It is now recognized that 'superficial' bladder carcinomas are a heterogenous group of tumors with diverse biological and clinical manifestations. The term 'superficial,' therefore, is no longer used for bladder tumor nomenclature. Recognition of diagnostic pitfalls associated with lamina propria invasion is critical for the evaluation of bladder tumor specimens. Neither the 1973 nor the 2004 WHO grading system appears to be useful for predicting the clinical outcome of invasive urothelial carcinoma. This review will discuss recent progress and controversial issues on the staging and substaging of bladder carcinomas. Essential elements for handling and reporting of bladder tumor specimens will also be discussed.
Cheng
Liang
L
Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, 350 West 11th Street, Clarian Pathology Laboratory Room 4010, Indianapolis, IN 46202, USA. liang_cheng@yahoo.com
Montironi
Rodolfo
R
Davidson
Darrell D
DD
Lopez-Beltran
Antonio
A
D002295:Carcinoma, Transitional Cell / Q000473:pathology*; D006801:Humans; D009367:Neoplasm Staging / Q000379:methods* / Q000592:standards; D010340:Pathology, Surgical / Q000379:methods* / Q000592:standards; D013048:Specimen Handling / Q000379:methods* / Q000592:standards; D001749:Urinary Bladder Neoplasms / Q000473:pathology*